-
AtriCure completes enrollment in stroke prevention trial
16 Jul 2025 00:46 GMT
… AtriClip system. [Image courtesy of AtriCure]
AtriCure
(Nasdaq: ATRC)
+
today announced … clinical evidence initiative that demonstrates AtriCure’s unwavering commitment to … to the exceptional team of clinical trial investigators and broader clinician …
-
AtriCure, Inc. (ATRC) Q4 2024 Earnings Call Transcript
13 Feb 2025 04:37 GMT
… the potential market opportunity for AtriCure's franchises and … clearances, competition, reimbursement and clinical trial outcomes. AtriCure's results may differ … materially from those projected. AtriCure undertakes no obligation to publicly …
-
AtriCure Reports Fourth Quarter 2024 and Full Year 2024 Financial Results
12 Feb 2025 21:21 GMT
… related to new product introductions, clinical trials and acquired IPR&D … days following the presentation.
About AtriCure
AtriCure, Inc. provides innovative technologies … GAAP Financial Measures
To supplement AtriCure’s condensed consolidated financial …
-
AtriCure leadership explains $45M investment in Greater Cincinnati HQ
19 Aug 2024 11:12 GMT
… low-cost environments.”
Alternatively, AtriCure (Nasdaq: ATRC) might … local high schools. AtriCure is the largest employer … from,” he said.
AtriCure focuses on cardiovascular conditions … company started the largest clinical trial ever done in cardiovascular …
-
AtriCure, Inc. (NASDAQ:ATRC) Q2 2024 Earnings Call Transcript
31 Jul 2024 12:48 GMT
… clearances, competition, reimbursement and clinical trial outcomes.
AtriCure’s results may differ materially … . This landmark and global clinical trial is expected to show a … in our LeAAPS clinical trial and resources focused on both clinical trials and new …
-
AtriCure, Inc. (NASDAQ:ATRC) Q1 2024 Earnings Call Transcript
02 May 2024 19:48 GMT
… approvals, clearances, reimbursement and clinical trial outcomes.
AtriCure’s results may differ … . If successful, this massive clinical trial along with existing robust clinical … devices. Enrollment in the LeAAPS clinical trial has continued rapidly, with …
-
AtriCure Announces the First Patient Treated in the LeAAPS™ Clinical Trial
31 Jan 2023 13:10 GMT
… , investigational device exemption (IDE) clinical trial to evaluate the safety and … atrial fibrillation and stroke.”
About AtriCure
AtriCure, Inc. provides innovative technologies … of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation …
-
AtriCure, Inc. (NASDAQ:ATRC) Q4 2023 Earnings Call Transcript
16 Feb 2024 16:37 GMT
… approvals, clearances, reimbursement and clinical trial outcomes.
AtriCure’s results may differ materially … Afib diagnosis through our LeAAPS clinical trial. The LeAAPS trial seeks … and expansion of our LeAAPS clinical trial and multiple product development …
-
AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results
15 Feb 2024 21:10 GMT
… driven by investments in clinical trials and product development initiatives outpacing … following the presentation.
About AtriCure
AtriCure, Inc. provides innovative technologies … Financial Measures
To supplement AtriCure’s condensed consolidated financial …
-
AtriCure Announces the First Patient Treated in the HEAL-IST Clinical Trial
07 Jun 2022 12:33 GMT
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced that the first patient was treated in the …